nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A CD44−/CD24+ phenotype is a poor prognostic marker in early invasive breast cancer
|
Ahmed, Mohamed A. H. |
|
2011 |
133 |
3 |
p. 979-995 |
artikel |
2 |
A comparative biomarker study of 514 matched cases of male and female breast cancer reveals gender-specific biological differences
|
Shaaban, Abeer M. |
|
2011 |
133 |
3 |
p. 949-958 |
artikel |
3 |
An in vitro investigation of metabolically sensitive biomarkers in breast cancer progression
|
Simpson, Natalie E. |
|
2011 |
133 |
3 |
p. 959-968 |
artikel |
4 |
A phase II study of afatinib (BIBW 2992), an irreversible ErbB family blocker, in patients with HER2-positive metastatic breast cancer progressing after trastuzumab
|
Lin, Nancy U. |
|
2012 |
133 |
3 |
p. 1057-1065 |
artikel |
5 |
A randomized trial of combination anastrozole plus gefitinib and of combination fulvestrant plus gefitinib in the treatment of postmenopausal women with hormone receptor positive metastatic breast cancer
|
Carlson, Robert W. |
|
2012 |
133 |
3 |
p. 1049-1056 |
artikel |
6 |
Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer
|
Cerliani, Juan P. |
|
2011 |
133 |
3 |
p. 997-1008 |
artikel |
7 |
Association of CD27 and CD70 gene polymorphisms with risk of sporadic breast cancer in Chinese women in Heilongjiang Province
|
Xu, Fengyan |
|
2012 |
133 |
3 |
p. 1105-1113 |
artikel |
8 |
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
|
Weigman, Victor J. |
|
2011 |
133 |
3 |
p. 865-880 |
artikel |
9 |
Benign thyroid disease is associated with breast cancer: a meta-analysis
|
Hardefeldt, Prue J. |
|
2012 |
133 |
3 |
p. 1169-1177 |
artikel |
10 |
Beyond taxanes: the next generation of microtubule-targeting agents
|
Cortes, Javier |
|
2011 |
133 |
3 |
p. 821-830 |
artikel |
11 |
Biologic features and prognosis of ductal carcinoma in situ are not adversely impacted by initial large body mass
|
Kuerer, Henry M. |
|
2012 |
133 |
3 |
p. 1131-1141 |
artikel |
12 |
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effort
|
Masciari, Serena |
|
2012 |
133 |
3 |
p. 1125-1130 |
artikel |
13 |
Case report and review of the literature: Secretory breast cancer in a 13-year-old boy—10 years of follow up
|
Cabello, Cesar |
|
2011 |
133 |
3 |
p. 813-820 |
artikel |
14 |
Correlation of breast cancer susceptibility loci with patient characteristics, metastasis-free survival, and mRNA expression of the nearest genes
|
Riaz, Muhammad |
|
2011 |
133 |
3 |
p. 843-851 |
artikel |
15 |
Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer
|
Lamond, Nathan W. D. |
|
2012 |
133 |
3 |
p. 1115-1123 |
artikel |
16 |
Differential oxidative status and immune characterization of the early and advanced stages of human breast cancer
|
Panis, C. |
|
2011 |
133 |
3 |
p. 881-888 |
artikel |
17 |
Ethanol promotes mammary tumor growth and angiogenesis: the involvement of chemoattractant factor MCP-1
|
Wang, Siying |
|
2011 |
133 |
3 |
p. 1037-1048 |
artikel |
18 |
Expression of SPRR3 is associated with tumor cell proliferation in less advanced stages of breast cancer
|
Kim, Jin Cheon |
|
2011 |
133 |
3 |
p. 909-916 |
artikel |
19 |
Family history and risk of breast cancer: nurses’ health study
|
Colditz, Graham A. |
|
2012 |
133 |
3 |
p. 1097-1104 |
artikel |
20 |
GPER mediates the Egr-1 expression induced by 17β-estradiol and 4-hydroxitamoxifen in breast and endometrial cancer cells
|
Vivacqua, Adele |
|
2011 |
133 |
3 |
p. 1025-1035 |
artikel |
21 |
High miR-26a and low CDC2 levels associate with decreased EZH2 expression and with favorable outcome on tamoxifen in metastatic breast cancer
|
Jansen, M. P. H. M. |
|
2011 |
133 |
3 |
p. 937-947 |
artikel |
22 |
25-Hydroxy vitamin-D, obesity, and associated variables as predictors of breast cancer risk and tamoxifen benefit in NSABP-P1
|
Amir, Eitan |
|
2012 |
133 |
3 |
p. 1077-1088 |
artikel |
23 |
Identification of copy number alterations associated with the progression of DCIS to invasive ductal carcinoma
|
Johnson, Clint E. |
|
2011 |
133 |
3 |
p. 889-898 |
artikel |
24 |
Investigation of human JC and BK polyomaviruses in breast carcinomas
|
Hachana, Mohamed |
|
2011 |
133 |
3 |
p. 969-977 |
artikel |
25 |
Local treatment of mixed osteolytic/osteoblastic spinal metastases: is photodynamic therapy effective?
|
Wise-Milestone, L. |
|
2011 |
133 |
3 |
p. 899-908 |
artikel |
26 |
Locoregional recurrence after breast cancer surgery: a systematic review by receptor phenotype
|
Lowery, Aoife J. |
|
2011 |
133 |
3 |
p. 831-841 |
artikel |
27 |
Paclitaxel sensitivity of breast cancer cells requires efficient mitotic arrest and disruption of Bcl-xL/Bak interaction
|
Flores, M. Luz |
|
2011 |
133 |
3 |
p. 917-928 |
artikel |
28 |
Polymorphisms of CYP19A1 and response to aromatase inhibitors in metastatic breast cancer patients
|
Ferraldeschi, Roberta |
|
2012 |
133 |
3 |
p. 1191-1198 |
artikel |
29 |
Prevalence of BRCA1 and BRCA2 mutations in non-familial breast cancer patients with high risks in Korea: The Korean Hereditary Breast Cancer (KOHBRA) Study
|
Son, Byung Ho |
|
2012 |
133 |
3 |
p. 1143-1152 |
artikel |
30 |
Progression of ductal carcinoma in situ to invasive breast cancer is associated with gene expression programs of EMT and myoepithelia
|
Knudsen, Erik S. |
|
2011 |
133 |
3 |
p. 1009-1024 |
artikel |
31 |
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition
|
Rouleau, E. |
|
2012 |
133 |
3 |
p. 1179-1190 |
artikel |
32 |
Recommendations for antiresorptive therapy in postmenopausal patients with breast cancer: Marburg AIBL Guideline Evaluation Study (MAGES)
|
Hadji, Peyman |
|
2012 |
133 |
3 |
p. 1089-1096 |
artikel |
33 |
Recurrent germline mutations in BRCA1 and BRCA2 genes in high risk families in Israel
|
Laitman, Yael |
|
2012 |
133 |
3 |
p. 1153-1157 |
artikel |
34 |
Second-line bevacizumab-containing therapy in patients with triple-negative breast cancer: subgroup analysis of the RIBBON-2 trial
|
Brufsky, Adam |
|
2012 |
133 |
3 |
p. 1067-1075 |
artikel |
35 |
The biological correlates of macroscopic breast tumour structure measured using fractal analysis in patients undergoing neoadjuvant chemotherapy
|
Di Giovanni, P. |
|
2012 |
133 |
3 |
p. 1199-1206 |
artikel |
36 |
Topoisomerase 2A gene amplification in breast cancer. Critical evaluation of different FISH probes
|
Varga, Zsuzsanna |
|
2011 |
133 |
3 |
p. 929-935 |
artikel |
37 |
Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration
|
Liao, Sheng-Jun |
|
2011 |
133 |
3 |
p. 853-863 |
artikel |
38 |
Vitamin D threshold to prevent aromatase inhibitor-related bone loss: the B-ABLE prospective cohort study
|
Prieto-Alhambra, Daniel |
|
2012 |
133 |
3 |
p. 1159-1167 |
artikel |